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Abstract 
 
Background: To compare the efficacy of short course of 
steroid with dimenhydrinate (antihistamine) in the 
treatment of intractable hyperemesis gravidarum. 
Methods:  In this descriptive study fifty patients   were  
assigned to receive  intravenous hydrocortisone 100 mg 
eight hourly as a daily dose for three  days.Subsequently, 
oral prednisolone 45 mg which was tapered off in 5 days. 
Fifty patients were given intravenous dimenhydrinate 50 
mg 3 times daily for 3 days, followed by oral tablets of 
50mg three times a day for 5 days . Patients were followed 
up daily during the therapy course and for 2 wks 
following  discharge . 
Results: There was a significant reduction in vomiting 
episodes in the hydrocortisone group compared with the 
dimenhydrinate   group (p < .0001). None of the  patient 
from the hydrocortisone group but eight of the patients 
receiving dimenhydrinate were readmitted for intractable 
vomiting within 1 wk after discharge. .  
Conclusion: Short corticosteroids’ course is an effective 
treatment for intractable hyperemesis gravidarum.  
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Introduction 
    Nausea and vomiting are the most common 
symptoms experienced in early pregnancy. Severe 
nausea and vomiting is associated with maternal 
morbidity although there is no evidence of fetal 
damage. Upto 3% of these women experience 
hyperemesis gravidarum, a severe form of vomiting 
due to pregnancy characterized by weight loss, 
electrolyte abnormalities, dehydration, and 
ketonuria.Complications associated with hyperemesis 
gravidarum include a tear in the mucosa at the 
junction of the esophagus and stomach (Mallory-Weiss 
tear) or an esophageal perforation and Wernicke 
encephalopathy, a neurological disorder characterized 
by confusion, disorientation, involuntary rolling of the 
eyeballs (nystagmus),double vision (diplopia), and 
coma, rhabdomyolysis,  coagulopathy, and low birth 
weight infants.  Severe dehydration can result in 
hypovolemia, leading to shock. Maternal failure to 
gain weight can cause intrauterine growth 
retardation.1-4 
       Symptoms usually start between 4 and 7 weeks 
gestation and resolve by 16th week. Serious 
complications are possible if condition is left 
untreated. Women with hyperemesis gravidarum who 
gain less than 15.4 pounds (7 kg) throughout the 
pregnancy are more likely to give birth to low birth 
weight infants and are thought to have an increased 
risk for preterm birth.5,6  
     The general care of women with severe 
hyperemesis extends beyond the use of steroid 
therapy. Mobilization must be gradual as physical 
movement exacerbates the underlying nausea. 
Discharge is not wise as soon as intravenous fluids are 
no longer necessary, as this may be associated with 
loss of control precipitated by the journey home. 6  
 
Patients and Methods 
       From January 2010 to December 2011, 100 women 
presenting to Gynae out patient department of District 
Head Quarter hospital complaining of nausea and 
vomiting during the first half of pregnancy (less than 
20 weeks' and more than 10 weeks gestation) were  
enrolled  to compare the efficacy of steroids with 
dimenhydrinate  group, both given intravenously for 
first 3 days and then orally for 5 days. 
     Women considered eligible for this study were 
those who previously had not responded to outpatient 
therapy and who demonstrated 3+ or 4+ dipstick 
urinary ketones as evidence of severe dehydration or 
weight loss of more than 5 percent of prepregnancy 
weight. Before enrollment into the study, an 
ultrasound was performed to exclude molar 
pregnancy, to confirm a live fetus, and to establish 
gestational age. All women underwent assessments of 
thyroid function, liver function, pancreas (amylase and 
lipase) and  electrolytes 
          All were  provided intravenous hydration with 
crystalloid until ketonuria cleared. The first litre of 
crystalloid included thiamine 100 mg.Women were 
assigned to two groups.Group A was given 
Journal of Rawalpindi Medical College (JRMC); 2012;16(1):59-61 
 
 60 
Hydrocortisone 100 mg intravenously for 3 days 
followed by tapering regimen of oral prednisone  (40 
mg for day 4, 30 mg for day 5, 20 mg for day 6, and 10 
mg for day 7).Group B was treated with 
dimenhydrinate 10mg intravenously every 8 hours  for 
3 days followed by the same regimen administered 
orally for 5 days until discharge from the hospital.      
Both groups of women were allowed to have small 
meals on request and were advanced to a regular diet 
as tolerated, at which time discharge was permitted. 
Each woman was counselled about diet, and told to 
have frequent small meals.At discharge, all women 
were instructed to report back, if vomiting recurred. 
Women requiring readmission for hyperemesis 
gravidarum. were given oral dimenhydrinate. 
   
Results 
         Hundred women were recruited between 
January 2010 to December 2011.Three patients were 
lost from follow up,two from the dimenhydrinate 
group and one from the steroid group. There were 62 
primigravidas. Gestational age was  between 10 weeks 
to 20 weeks (Table 1). Adverse effects of drug  were 
not found in any patient. Severity  of hyperemesis 
gravidarum was assessed by number of vomits  per 
day  and weight loss in the current pregnancy as 
compared to prepregnancy weight,and it was almost 
similar between  two groups(Table 1).  
      After one week of  treatment, eight women in 
steroid group and twenty women in dimenhydrinate 
group were still vomiting,of whom three in steroid 
group and sixteen in dimenhydrinate group were 
vomiting  five or more than five times daily (Table 
2).Patients who were vomiting more than five times a 
day were continued on intravenous therapy  for three 
more days. 
 
Table 1: Patients’ Characteristics  (n=97) 
Characterisitcs  Group A 
steroid(n=49)  
Group B 
dimenhydrinate(n=48) 
Primigravidas  28(56%) 34(68%) 
Multigravidas 
(gestation>3) 
12(24%) 26(52%) 
Gestation(weeks)
;mean(SD) 
13.2SD(2.5) 11.5SD(2.1) 
Weight 
(kg);mean(SD) 
61.8(10.2) 58.3(12.5) 
No of vomits > 5 
times per day 
32(64%) 37(74%) 
 
      Twenty five women, on steroids, achieved 
suppression of vomiting within 48 hours ,while 16 felt 
better after one week of therapy . 8 patients were still 
vomiting at the end of one week therapy and 1 patient 
was lost to follow up. As for Dimenhydrinate group 11 
patients achieved suppression of vomiting within 48 
hours while 17 patients felt better after one week of 
treatment ,20 patients were still vomiting and 2 were 
lost to  follow up.Control of vomiting was much better 
with steroids because number of patients still 
requiring intravenous infusions at the end of first 
week therapy was only 3 in steroid group as compared 
to 16 in dimenhydrinate group. 
Number of patients requiring antiemetics at 
the end of first week  of treatment was 8 in steroid 
group as compared to 20 in dimenhydrinate group. 
Seven patients from the dimenhydrinate group were  
readmitted within one week after  discharge but no 
patient from the steroid group was readmitted (Table 
3)There was a significantly greater improvement in the 
well being rate in the steroid group .Majority 
(67.32%)patients in the steroid group were tolerating 
oral  food well at two weeks follow up,compared to 
39.58% in dimenhydrinate group . 
 
Table2.Primary outcome measures 
 Steroid
(n=49) 
Dimenhydrinate
(n=48)    
 p value 
No of patients 
with l 
vomiting after 
I week 
8 20 0.00<.05 
No of  
patients  on 
intravenous 
infusion 
3 16 0.00<.05 
 
Table 3. Secondary outcome measures 
 Steroid 
group 
Dimenhydri
nate group 
RR(95
% CI) 
p- value 
Readmission 
of patients 
0 7 1.8791 0.00 
Patients on 
antiemetics 
8 20 1.6305 0.00 
Well being 
rate after 2 
weeks 
33 19 1.3804 0.00 
Data are expressed as median (range). Relative risk (RR) and (95% 
confidence interval) are given for proportions RR (95% CI) 
 
Discussion 
      Severe hyperemesis gravidarum causes 
profound maternal morbidity. Indications for the use 
of steroids in hyperemesis gravidarum are delineated. 
Most protocols suggest using steroids after the 10th 
week of pregnancy and limiting their use to one 
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month. The initial dose is typically high, then weaned 
down slowly after a few days. Present study registered 
 cessation of vomiting was observed in most of the 
patients after initial dose of intravenous 
hydrocortisone. Maintainence prednisolone therapy  
permitted discharge from hospital within days, 
resumption of normal eating, reversal of muscle 
wasting and regain of lost weight ,mean loss from 
prepregnant weight . Steroid use is typically saved for 
women who do not respond to other medications by 
the end of the first trimester, and are losing weight 
rapidly due to more severe nausea and vomiting. Use 
of steroids for hyperemesis gravidarum revealed 
benefits with respect of patients’ well being, food 
intake and weight gain. 7-10 Studies have found   
adverse effects on the baby since the treatment 
duration is typically a month or less. Transplacental 
passage of prednisolone is low, which predicts 
minimal effect on fetus. 11 
    There has been much anxiety in the past,concerning 
a possible association between steroid use in first 
trimester and oral facial clefts ,the study of Rodriguez-
Pinilla and Martinez-Frias is often quoted as 
demonstrating a significant effect of first trimester 
steroid use and cleft lip and palate,but three of the five 
identified cases appear unlikely to be relevant12. One 
of the three received only two doses of prednisolone 
after eight weeks gestation when lip fusion would 
have already occurred, another was associated with 
multiple abnormalities and a third was receiving 
replacement doses of hydrocortisone. A larger  study 
found oral cleft rates to be similar between controls 
and those taking steroids in the first trimester and 
failed to show any association between steroid use in 
the first trimester and oral facial clefts.13 
      Although the severity of vomiting necessary for 
admission to the trial was specified, vomiting in 
pregnancy can have a variety of causes.Thus some 
women may have vomiting purely because of the 
hormonal effects of pregnancy but in others,emotional 
factors may have been dominant. 
 
Conclusion 
Steroid therapy,for hyperemesis gravidarum,  after 
tenth week of gestation, will circumvent maternal and 
fetal deleterious implications   
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